Pierre Remy is a Founding and Managing Partner at Keensight Capital. See sector focus and contact routes.
Pierre Remy is a Founding and Managing Partner at Keensight Capital, where he leads the Healthcare & Wellbeing practice after spending 10 years as Managing Partner of R Capital at Rothschild & Co. His investment thesis focuses on growth buyouts and private equity in healthcare sectors—including orthopedics, dental, cardiovascular, and biopharmaceuticals—as well as information technology, primarily targeting French and European companies to scale them into intermediate-sized enterprises. Typical check sizes range from €10 million to €50 million for companies with approximately €10 million in revenue, with Keensight acting as a lead investor in capital-development deals. Notable portfolio companies include Biovian, where Remy serves as Chairman, LDR Spine (formerly LDR Holding Corp.), Tecres Spa, and Unither Pharmaceuticals, all reflecting his deep medical technology and biopharma focus. Remy has publicly helped portfolio companies complete Nasdaq IPOs and emphasizes international expansion as a core value driver, though no distinctive public writing or unique point-of-view articles are cited in available sources.
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Paris.
Investors like Pierre Remy · Full investor directory · Investor access · Company funding database